Brief: Immix Biopharma Prices Offering Of 19.1 Million Shares At $5.10 Per Share
Dec 8 (Reuters) - Immix Biopharma Inc IMMX.O: IMMIX BIOPHARMA ANNOUNCES PRICING OF UPSIZED $100 MILLION UNDERWRITTEN OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS IMMIX BIOPHARMA INC - PRICES OFFERING OF 19.1 MILLION SHARES AT $5.10 PER SHARE Source text: ID:nGNX32mYdP Further company coverage: IMMX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary